OR WAIT null SECS
March 21, 2022
FDA has approved Opdualag for adults and pediatric patients 12 years of age and older with unresectable or metastatic melanoma.
FDA has approved ZTALMY as a treatment for seizures associated with CDKL5 deficiency disorder (CDD).
Moderna has reached an agreement with the Ministry of Health, Labor, and Welfare of Japan (MHLW) to supply Japan with an additional 70 million doses of its COVID-19 Booster Vaccine.
physIQ and CellCarta are conducting a study to evaluate individual patient response to vaccination using wearable biosensors.
March 18, 2022
Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.
Sanofi and Seagen have entered an agreement to investigate three cancer targets.
March 17, 2022
BioMed X and Merck KGaA, Darmstadt, Germany announced their collaboration on a research project to study T-cells and autoimmunity.
March 16, 2022
EMA has recommended that possible side effects of Spikevax and Janssen COVID-19 vaccines be added to product information.
NIH has launched one of the first Phase 1 clinical trials to examine mRNA technology for HIV.
March 14, 2022
Flow Eighteeen38 is receiving a €5 million (US$5.58 million) investment from its parent company, FairJourney Biologics.